217 related articles for article (PubMed ID: 38520016)
1. Statins as a risk factor for diabetic retinopathy: a Mendelian randomization and cross-sectional observational study.
Chen C; Zhang H; Lan Y; Yan W; Liu S; Chen Y; Xie T; Ning J; Yan X; Shang L; Han J
J Transl Med; 2024 Mar; 22(1):298. PubMed ID: 38520016
[TBL] [Abstract][Full Text] [Related]
2. Causal effects of diabetic retinopathy on depression, anxiety and bipolar disorder in the European population: a Mendelian randomization study.
Chen C; Lan Y; Wang Z; Yan W; Yan X; Han J
J Endocrinol Invest; 2024 Mar; 47(3):585-592. PubMed ID: 37598399
[TBL] [Abstract][Full Text] [Related]
3. The causal effect of hypertension, intraocular pressure, and diabetic retinopathy: a Mendelian randomization study.
Wang XF; Zhang XW; Liu YJ; Zheng XY; Su MR; Sun XH; Jiang F; Liu ZN
Front Endocrinol (Lausanne); 2024; 15():1304512. PubMed ID: 38379860
[TBL] [Abstract][Full Text] [Related]
4. Associations of genetically determined lipid traits and lipid-modifying agents with the risk of diabetic retinopathy: A Mendelian randomization study.
Li N; Zhang X; Zhang M; Wu L; Li C; Pan Y; Wang W; Ji J; Zheng D
Atherosclerosis; 2023 Mar; 369():9-16. PubMed ID: 36827905
[TBL] [Abstract][Full Text] [Related]
5. No causal association between serum vitamin D levels and diabetes retinopathy: A Mendelian randomization analysis.
Huang C; Luo D; Sun M; Fang G; Wei M; Zhang Y; Wang J; Huang Y
Nutr Metab Cardiovasc Dis; 2024 May; 34(5):1295-1304. PubMed ID: 38508994
[TBL] [Abstract][Full Text] [Related]
6. Association of HMGCR inhibition with rheumatoid arthritis: a Mendelian randomization and colocalization study.
Ma L; Du Y; Ma C; Liu M
Front Endocrinol (Lausanne); 2023; 14():1272167. PubMed ID: 38047111
[TBL] [Abstract][Full Text] [Related]
7. Correlation between diabetic retinopathy and diabetic nephropathy: a two-sample Mendelian randomization study.
Fang J; Luo C; Zhang D; He Q; Liu L
Front Endocrinol (Lausanne); 2023; 14():1265711. PubMed ID: 38027162
[TBL] [Abstract][Full Text] [Related]
8. Causal relationships between blood metabolites and diabetic retinopathy: a two-sample Mendelian randomization study.
Yang C; Ma Y; Yao M; Jiang Q; Xue J
Front Endocrinol (Lausanne); 2024; 15():1383035. PubMed ID: 38752182
[TBL] [Abstract][Full Text] [Related]
9. Association of lipid-lowering drugs with COVID-19 outcomes from a Mendelian randomization study.
Huang W; Xiao J; Ji J; Chen L
Elife; 2021 Dec; 10():. PubMed ID: 34866576
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease as a causal risk factor for diabetic retinopathy: a Mendelian randomization study.
Ouyang F; Yuan P; Ju Y; Chen W; Peng Z; Xu H
Front Endocrinol (Lausanne); 2024; 15():1340608. PubMed ID: 38699385
[TBL] [Abstract][Full Text] [Related]
11. The causal effect of obesity on diabetic retinopathy: A two-sample Mendelian randomization study.
Zheng C; Wei X; Cao X
Front Endocrinol (Lausanne); 2023; 14():1108731. PubMed ID: 37077358
[TBL] [Abstract][Full Text] [Related]
12. Causal effects of gut microbiota on diabetic retinopathy: A Mendelian randomization study.
Liu K; Zou J; Fan H; Hu H; You Z
Front Immunol; 2022; 13():930318. PubMed ID: 36159877
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in targets of lipid-lowering drugs and amyotrophic lateral sclerosis risk: a Mendelian randomization study.
Li Z; Tian M; Jia H; Li X; Liu Q; Zhou X; Li R; Dong H; Liu Y
Amyotroph Lateral Scler Frontotemporal Degener; 2024 Feb; 25(1-2):197-206. PubMed ID: 37688479
[TBL] [Abstract][Full Text] [Related]
14. The association of alanine aminotransferase and diabetic microvascular complications: A Mendelian randomization study.
Bi Y; Liu Y; Wang H; Tian S; Sun C
Front Endocrinol (Lausanne); 2023; 14():1104963. PubMed ID: 36742400
[TBL] [Abstract][Full Text] [Related]
15. Association of lipid-lowering drug targets with risk of cutaneous melanoma: a mendelian randomization study.
Miao L; Miao T; Zhang Y; Hao J
BMC Cancer; 2024 May; 24(1):602. PubMed ID: 38760735
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the association between genetic factors regulating thyroid function and microvascular complications in diabetes: A two-sample Mendelian randomization study in the European population.
Li H; Li M; Dong S; Zhang S; Dong A; Zhang M
Front Endocrinol (Lausanne); 2023; 14():1126339. PubMed ID: 36926020
[TBL] [Abstract][Full Text] [Related]
17. Genetic insights into repurposing statins for hyperthyroidism prevention: a drug-target Mendelian randomization study.
Huang A; Wu X; Lin J; Wei C; Xu W
Front Endocrinol (Lausanne); 2024; 15():1331031. PubMed ID: 38425755
[TBL] [Abstract][Full Text] [Related]
18. Integrative analysis of Mendelian randomization and gene expression profiles reveals a null causal relationship between adiponectin and diabetic retinopathy.
Zhang A; Wu H; Wang C; Tian S
Adipocyte; 2023 Dec; 12(1):2234522. PubMed ID: 37459460
[TBL] [Abstract][Full Text] [Related]
19. Diabetic retinopathy risk in patients with unhealthy lifestyle: A Mendelian randomization study.
Su Z; Wu Z; Liang X; Xie M; Xie J; Li H; Wang X; Jiang F
Front Endocrinol (Lausanne); 2022; 13():1087965. PubMed ID: 36733810
[TBL] [Abstract][Full Text] [Related]
20. Effect of statins on sepsis and inflammatory factors: A Mendelian randomization study.
Zhang K; Liu W; Liang H
Eur J Clin Invest; 2024 May; 54(5):e14164. PubMed ID: 38229409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
